4Francois CG, Breidenbach WC, Maldonado C, et al. Hand transplantation: comparisons and observations of the first four clinical cases. Microsurgery, 2000, 20: 360-371.
8Starzl TE, Demetris AJ, Murase N, et al. Cell migration, chimerism, and graft acceptance. Lancet, 1992, 339: 1579-1582.
9Hewitt CW. Update and outline of the experimental problems facing clinical composite tissue transplantation. Transplant Proc, 1998, 30: 2704-2407.
10Lee WP, Mathes DW. Hand transplantation: pertinent data and future outlook. J Hand Surg (Am), 1999, 24: 906-913.
二级参考文献12
1裴国献，中华医学杂志，2000年，80卷，417页
2苏泽轩，现代移植学，1998年，393页
3Benhaim P，Trans plantation，1993年，56卷，911页
4Dubernard JM, Oven E, Herzberg G, et al. Human hand allo graft:report on first 6 months. Lancet, 1999,353: 1315-1320.
5Liuii R. An open proposal for clinical composite tissue allotransplantation. Transplant Proc, 1998, 30: 2692-2696.
6Sawada S, Suzuk G, Kawase Y, et al. Novel immunosuppressive agent, FKS06 in vitro effects on the cloned T cell activation. J Immunol, 1987, 139: 1791-1803.
7Barker JH, Jones JN, Breidenbrack WC. Proceedings of the In temational symposium on composice tissue allotransplantaion: colosing remarks. Transplant Proc, 1998, 30: 2787.
8Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet, 1999, 353: 1315-1320.
3Starzl TE,Demetris AJ,Murase N. Cell migration,chimerism,and graft acceptance[J].Lancet,1992.1579-1582.
4Levy AE,Alexander JW,Babcock GF. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts[J].Transplant Immunology,1997.83-88.doi:10.1016/S0966-3274(97)80047-0.
5Adams AB,Durham MM,Kean L. Costimulation blockade,busulfan,and bone marrow promote titratable macrochimerism,induce transplantation tolerance,and correct genetic hemoglobinopathies with minimal myelosuppression[J].Journal of Immunology,2001.1103-1111.
6Kawai T,Cosimi AB,Wee SL. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys[J].Transplantation,2002.1757-1764.doi:10.1097/00007890-200206150-00011.
7Donckier V,Toungouz M,Goldman M. Transplantation tolerance and mixed chimerism:at the frontier of clinical application[J].Transplant International,2001,(1):1-5.doi:10.1111/j.1432-2277.2001.tb00001.x.
8Ruggeri L,Capanni M,Urbani E. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J].Science,2002.2097-2100.doi:10.1126/science.1068440.
9Lee WP,Buttler PE,Randolph MA. Donor modification leads to prolonged survival of limb allografts[J].Plastic and Reconstructive Surgery,2001,(5):1235-1241.doi:10.1097/00006534-200110000-00021.
10Foster RD,Ascher NL,McCalmont TH. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers[J].Transplantation,2001,(5):791-797.doi:10.1097/00007890-200109150-00009.
